Literature DB >> 24994607

Plasma lactate and incident hypertension in the atherosclerosis risk in communities study.

Stephen P Juraschek1, Julie K Bower2, Elizabeth Selvin1, Ghanshyam Palamaner Subash Shantha2, Ron C Hoogeveen3, Christie M Ballantyne3, J Hunter Young4.   

Abstract

BACKGROUND: Recent evidence suggests that insufficient oxidative capacity or mitochondrial dysfunction may play a causal role in the development of high blood pressure. However, this hypothesis has not been tested in the general population. We hypothesized that lactate, a measure of oxidative capacity, would be positively associated with incident hypertension even after accounting for traditional hypertension risk factors.
METHODS: Plasma lactate was measured in 5,554 participants from the Atherosclerosis Risk in Communities (ARIC) Study with no subclinical or diagnosed hypertension at baseline (1996-1998). Incident hypertension was defined by self-report or hypertension medication use. Analyses were performed with Cox proportional hazards models.
RESULTS: The mean age was 61.9 years, and the mean lactate was 0.8 mmol/L. During a median follow-up period of 11.9 years (range = 26.9 days to 13.4 years), there were 3,849 new cases of hypertension. The fourth quartile of lactate (compared with the first quartile) was associated with an elevated risk of hypertension (hazard ratio (HR) = 1.18; 95% confidence interval (CI) = 1.07-1.31) even after adjustment for traditional risk factors, including baseline systolic and diastolic blood pressure. This association was stronger when the population was restricted to participants with normal blood pressure (<120mm Hg/<80mm Hg; HR = 1.42; 95% CI = 1.23-1.63). In strata of sex, the association was strong in women vs. null in men (P interaction = 0.01).
CONCLUSIONS: Plasma lactate is associated with incident hypertension in women, especially with a normal blood pressure (<120mm Hg/<80mm Hg). Future studies should elucidate the mechanisms underlying these observations. © American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  ARIC; blood pressure; cohort; hypertension; lactate.

Mesh:

Substances:

Year:  2014        PMID: 24994607      PMCID: PMC4357800          DOI: 10.1093/ajh/hpu117

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  39 in total

1.  Exercise training restores the endothelial progenitor cells number and function in hypertension: implications for angiogenesis.

Authors:  Tiago Fernandes; Juliana S Nakamuta; Flávio C Magalhães; Fernanda R Roque; Carolina Lavini-Ramos; Isolmar T Schettert; Verônica Coelho; José E Krieger; Edilamar M Oliveira
Journal:  J Hypertens       Date:  2012-11       Impact factor: 4.844

2.  Exercise and ovarian steroid hormones: their effects on mitochondrial respiration.

Authors:  I Gigli; L E Bussmann
Journal:  Life Sci       Date:  2001-02-16       Impact factor: 5.037

3.  Lactate metabolism shift in CHO cell culture: the role of mitochondrial oxidative activity.

Authors:  Francesca Zagari; Martin Jordan; Matthieu Stettler; Hervé Broly; Florian M Wurm
Journal:  N Biotechnol       Date:  2012-06-06       Impact factor: 5.079

4.  Validity and reliability of self-reported diabetes in the Atherosclerosis Risk in Communities Study.

Authors:  Andrea L C Schneider; James S Pankow; Gerardo Heiss; Elizabeth Selvin
Journal:  Am J Epidemiol       Date:  2012-09-25       Impact factor: 4.897

5.  The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.

Authors:  Timothy D Henry; Brian H Annex; George R McKendall; Michael A Azrin; John J Lopez; Frank J Giordano; P K Shah; James T Willerson; Raymond L Benza; Daniel S Berman; C Michael Gibson; Alex Bajamonde; Amy Chen Rundle; Jennifer Fine; Edward R McCluskey
Journal:  Circulation       Date:  2003-03-18       Impact factor: 29.690

6.  Long-standing, insulin-treated type 2 diabetes patients with complications respond well to short-term resistance and interval exercise training.

Authors:  S F E Praet; R A M Jonkers; G Schep; C D A Stehouwer; H Kuipers; H A Keizer; L J van Loon
Journal:  Eur J Endocrinol       Date:  2008-02       Impact factor: 6.664

7.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

8.  Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study.

Authors:  Bruce B Duncan; Maria Inês Schmidt; James S Pankow; Christie M Ballantyne; David Couper; Alvaro Vigo; Ron Hoogeveen; Aaron R Folsom; Gerardo Heiss
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

9.  Sex differences in cardiovascular outcomes in patients with incident hypertension.

Authors:  Stacie L Daugherty; Frederick A Masoudi; Chan Zeng; P Michael Ho; Karen L Margolis; Patrick J O'Connor; Alan S Go; David J Magid
Journal:  J Hypertens       Date:  2013-02       Impact factor: 4.844

10.  Hypoxia decreases insulin signaling pathways in adipocytes.

Authors:  Claire Regazzetti; Pascal Peraldi; Thierry Grémeaux; Rosanna Najem-Lendom; Issam Ben-Sahra; Mireille Cormont; Frédéric Bost; Yannick Le Marchand-Brustel; Jean-François Tanti; Sophie Giorgetti-Peraldi
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

View more
  15 in total

1.  Gut dysbiosis is linked to hypertension.

Authors:  Tao Yang; Monica M Santisteban; Vermali Rodriguez; Eric Li; Niousha Ahmari; Jessica Marulanda Carvajal; Mojgan Zadeh; Minghao Gong; Yanfei Qi; Jasenka Zubcevic; Bikash Sahay; Carl J Pepine; Mohan K Raizada; Mansour Mohamadzadeh
Journal:  Hypertension       Date:  2015-04-13       Impact factor: 10.190

2.  Late life socioeconomic status and hypertension in an aging cohort: the Atherosclerosis Risk in Communities Study.

Authors:  M Maya McDoom; Priya Palta; Priya Vart; Stephen P Juraschek; Anna Kucharska-Newton; Ana V Diez Roux; Josef Coresh
Journal:  J Hypertens       Date:  2018-06       Impact factor: 4.844

3.  Role of the Gut Microbiome in Obstructive Sleep Apnea-Induced Hypertension.

Authors:  David J Durgan; Bhanu P Ganesh; Julia L Cope; Nadim J Ajami; Sharon C Phillips; Joseph F Petrosino; Emily B Hollister; Robert M Bryan
Journal:  Hypertension       Date:  2015-12-28       Impact factor: 10.190

4.  Hypertension after kidney donation: Incidence, predictors, and correlates.

Authors:  Otto A Sanchez; Laine K Ferrara; Sarah Rein; Danielle Berglund; Arthur J Matas; Hassan N Ibrahim
Journal:  Am J Transplant       Date:  2018-04-06       Impact factor: 8.086

5.  Alterations in the gut microbiota can elicit hypertension in rats.

Authors:  Sareema Adnan; James W Nelson; Nadim J Ajami; Venugopal R Venna; Joseph F Petrosino; Robert M Bryan; David J Durgan
Journal:  Physiol Genomics       Date:  2016-12-23       Impact factor: 3.107

Review 6.  The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.

Authors:  Mehmet Kanbay; Emine M Onal; Baris Afsar; Tuncay Dagel; Aslihan Yerlikaya; Adrian Covic; Nosratola D Vaziri
Journal:  Int Urol Nephrol       Date:  2018-05-04       Impact factor: 2.370

Review 7.  The gut microbiome as a target for adjuvant therapy in obstructive sleep apnea.

Authors:  Mohammad Badran; Saif Mashaqi; David Gozal
Journal:  Expert Opin Ther Targets       Date:  2020-12-04       Impact factor: 6.797

8.  Physical fitness and hypertension in a population at risk for cardiovascular disease: the Henry Ford ExercIse Testing (FIT) Project.

Authors:  Stephen P Juraschek; Michael J Blaha; Seamus P Whelton; Roger Blumenthal; Steven R Jones; Steven J Keteyian; John Schairer; Clinton A Brawner; Mouaz H Al-Mallah
Journal:  J Am Heart Assoc       Date:  2014-12       Impact factor: 5.501

9.  Outcome of Stable Patients With Acute Myocardial Infarction and Coronary Artery Bypass Surgery Within 48 Hours: A Single-Center, Retrospective Experience.

Authors:  Christina Grothusen; Christine Friedrich; Johannes Loehr; Jette Meinert; Eva Ohnewald; Ulysses Ulbricht; Tim Attmann; Assad Haneya; Katharina Huenges; Sandra Freitag-Wolf; Jan Schoettler; Jochen Cremer
Journal:  J Am Heart Assoc       Date:  2017-10-03       Impact factor: 5.501

Review 10.  Proton Transport Chains in Glucose Metabolism: Mind the Proton.

Authors:  Dirk Roosterman; Wolfgang Meyerhof; Graeme S Cottrell
Journal:  Front Neurosci       Date:  2018-06-15       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.